Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' reply
Aliment Pharmacol Ther
.
2020 Sep;52(5):925-926.
doi: 10.1111/apt.15942.
Authors
Perttu Lahtinen
1
2
,
Jonna Jalanka
3
,
Anna Hartikainen
3
,
Eero Mattila
4
,
Markku Hillilä
2
5
,
Jari Punkkinen
6
,
Jari Koskenpato
7
,
Veli-Jukka Anttila
2
4
,
Jyrki Tillonen
1
,
Reetta Satokari
3
,
Perttu Arkkila
2
8
Affiliations
1
Department of Gastroenterology, Päijät-Häme Central Hospital, Lahti, Finland.
2
Faculty of Medicine, University of Helsinki, Helsinki, Finland.
3
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
4
Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
5
Department of Gastroenterology, Helsinki University Hospital, Espoo, Finland.
6
Department of Gastroenterology, Porvoo Hospital, Porvoo, Finland.
7
Department of Gastroenterology, Aava Medical Centre, Helsinki, Finland.
8
Department of Gastroenterology, Helsinki University Hospital, Helsinki, Finland.
PMID:
32852821
DOI:
10.1111/apt.15942
No abstract available
Publication types
Letter
Comment
MeSH terms
Colonoscopy
Fecal Microbiota Transplantation
Humans
Irritable Bowel Syndrome* / therapy